Bioxytran, Inc. announced effective as of April 19, 2024, the company has elected Dr. Radka Milanova, to fill the vacancy left by Dr. Chen-Walden, (now deceased). Dr. Radka Milanova holds a PhD in Organic Chemistry from Simon Fraser University, Canada. Dr. Milanova?s professional experience includes executive positions with various biotechnology companies.

She has championed and captained five Investigational New Drug Applications (IND) and two successful New Drug Applications (NDA), lead Research and Development programs, invented eight granted patents and seventeen publications, obtained millions in grants, associated with licensing deals, and business development agreements that achieved winning commercialization results, maximizing global market share and generating millions in revenues.